Sign Up to like & get recommendations! 1
Published in 2022 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12259
Abstract: Lurasidone has few metabolic adverse effects and is recommended as an alternative when other antipsychotic drugs considerably increase body weight or blood sugar concentrations. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of the Formosan Medical Association = Taiwan yi zhi"
DOI: 10.1016/j.jfma.2019.11.015
Abstract: Sodium-glucose cotransporter-2 (SGLT-2) inhibitors have become the best choice of second-line oral antidiabetic drugs for patients with heart or chronic kidney disease. However, it is not clear how safe this treatment is for elderly patients,… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofaa439.373
Abstract: Background: One of the risk factors for poor outcome with SARS-CoV-2 infection is diabetes mellitus;diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are the most serious complications of diabetes mellitus We aimed to explore the… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000007369
Abstract: Rationale: A hyperosmolar hyperglycemic state (HHS) is a rare presentation of a hyperglycemic crisis in children with diabetes mellitus. As this condition can be fatal and has high morbidity, early recognition and proper management are… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000013647
Abstract: Rationale: Acute kidney injury is common and correctable in patients with a hyperosmolar hyperglycemic state (HHS). Nevertheless, hyperglycemic crisis may also contribute to the development of rhabdomyolysis, which can worsen renal function and lead to… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000001153
Abstract: To the Editor: Tacrolimus is an immunosuppressant used in organ transplant recipients to decrease the risk of rejection. It is known to cause hyperglycemia through multiple mechanisms. Studies have shown that it induces insulin resistance… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "International Journal of Emergency Medicine"
DOI: 10.1186/s12245-025-01078-w
Abstract: Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are life-threatening acute complications of diabetes. Up to one-third of patients present with overlapping features of both syndromes, complicating diagnosis and management. This overlap is associated with… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvaf149.994
Abstract: Abstract Disclosure: F.O. Asemota: None. L. Sangurima: None. A. Sajan: None. Introduction: Rhabdomyolysis is a rare sequelae of hyperosmolar hyperglycemic state (HHS). We present a case of HHS complicated by rhabdomyolysis resulting in mortality. Case:… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Journal of Neurosciences in Rural Practice"
DOI: 10.25259/jnrp_194_2025
Abstract: Hyperosmolar hyperglycemic state (HHS) is a severe complication of diabetes mellitus (DM), often triggered by acute illnesses such as stroke. A 68-year-old female with hypertension and type 2 DM presented with recurrent seizures and right-sided… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12020302
Abstract: Background: Previous studies in Western countries have shown that a hyperosmolar hyperglycemic state (HHS) is associated with an increased risk of venous thromboembolism (VTE); in these cases, prophylactic anticoagulant treatment is suggested. However, the association… read more here.